Skip to main content
Log in

Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient

  • Short Communication
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic inflammatory disease of the spinal cord in which HTLV-I Tax-specific cytotoxic T lymphocytes (CTL) have been suggested to be immunopathogenic. However, it is unknown whether the HTLV-I-specific CTL in the central nervous system differ from those in the periphery. We investigated functional T-cell receptor diversity in HTLV-I Tax11-19-specific CTL clones derived from peripheral blood and cerebrospinal fluid (CSF) of a HAM/TSP patient using analogue peptides of the viral antigen. CTL responses to the analogue peptides varied between T-cell clones, however, CTL clones from CSF showed limited recognition of the peptides when compared to those from peripheral blood. This suggests that CTL with highly focused specificity for HTLV-I Tax accumulate in the CSF and may contribute to the pathogenesis of HAM/TSP. Furthermore, this study provides a rationale for analogue peptide-based immunotherapeutic strategies focusing on the immunopathogenic T-cells in HTLV-I-associated neurologic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R (2000). Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 6: 1167–1175.

    Article  CAS  PubMed  Google Scholar 

  • Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC (1998). Two human T-cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8: 403–411.

    Article  CAS  PubMed  Google Scholar 

  • Evavold BD, Allen PM (1991). Separation of IL-4 production from Th cell proliferation by an altered T-cell receptor ligand. Science 252: 1308–1310.

    Article  CAS  PubMed  Google Scholar 

  • Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407–410.

    Article  CAS  PubMed  Google Scholar 

  • Gran B, Hemmer B, Vergelli M, McFarland HF, Martin R (1999). Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 45: 559–567.

    Article  CAS  PubMed  Google Scholar 

  • Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP (1998). Direct visualization of antigen-specific T-cells: HTLV-1 Tax11-19-specific CD8+ T-cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 95: 7568–7573.

    Article  CAS  PubMed  Google Scholar 

  • Hemmer B, Vergelli M, Tranquill L, Conlon P, Ling N, McFarland HF, Martin R (1997). Human T-cell response to myelin basic protein peptide (83–99): extensive heterogeneity in antigen recognition, function, and phenotype. Neurology 49: 1116–1126.

    CAS  PubMed  Google Scholar 

  • Jacobson S (1996). Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 13: S100-S106, Suppl. 1.

    Article  PubMed  Google Scholar 

  • Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245–248.

    Article  CAS  PubMed  Google Scholar 

  • Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L, the altered peptide ligand in relapsing MS study group (2000). Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nat Med 6: 1176–1182.

    Article  CAS  PubMed  Google Scholar 

  • Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (1998). Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161: 482–488.

    CAS  PubMed  Google Scholar 

  • Kubota R, Soldan SS, Martin R, Jacobson S (2000). An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease. J Immunol 164: 5192–5198.

    CAS  PubMed  Google Scholar 

  • Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S (1997). Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med 336: 839–845.

    Article  CAS  PubMed  Google Scholar 

  • Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M (1999). Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J NeuroVirol 5: 241–248.

    Article  CAS  PubMed  Google Scholar 

  • Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT (1996). Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84–90.

    Article  CAS  PubMed  Google Scholar 

  • Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987). Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21: 117–122.

    Article  CAS  PubMed  Google Scholar 

  • Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031–1032.

    Article  CAS  PubMed  Google Scholar 

  • Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M (1993). Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52: 424–430.

    Article  CAS  PubMed  Google Scholar 

  • Utz U, Banks D, Jacobson S, Biddison WE (1996). Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J Virol 70: 843–851.

    CAS  PubMed  Google Scholar 

  • Utz U, Brooks JA, McFarland HF, Martin R, Biddison WE (1994). Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T-cells increases with severity of multiple sclerosis. Proc Natl Acad Sci USA 91: 5567–5571.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Jacobson.

Additional information

This article is not subject to U.S. copyright laws.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubota, R., Soldan, S.S., Martin, R. et al. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient. Journal of NeuroVirology 8, 53–57 (2002). https://doi.org/10.1080/135502802317247811

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/135502802317247811

Keywords

Navigation